CRDL EPS Estimates
Cardiol Therapeutics Inc.
$1.15
+$0.01(+0.88%)
27
Overall
40
Value
18
Tech
23
Quality
Market Cap
$135.79M
Volume
570.50K
52W Range
$0.88 - $2.34
Target Price
$7.99
CRDL EPS estimates: the consensus estimate for Cardiol Therapeutics Inc.'s current fiscal year is -$0.19 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CRDL EPS Estimates
- EPS estimate, current quarter
- $-0.05
- EPS estimate, next quarter
- $-0.05
- EPS estimate, current year
- $-0.19
- EPS estimate, next year
- $-0.24
- EPS growth, 3-year
- +7.33%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.39 |
| 2024 | $-0.51 |
| 2023 | $-0.44 |
| 2022 | $-0.49 |
| 2021 | $-0.73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDL | $1.15 | +0.9% | 570.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cardiol Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW